Faron Pharmaceuticals Oy (FARN) Stock Statistics & Valuation Metrics

Faron Pharmaceuticals Oy has a market cap or net worth of GBX 62.32M. The enterprise value is GBX 60.49M.

Market Cap

GBX 62.32M

Enterprise Value

GBX 60.49M

Faron Pharmaceuticals Oy has 227,881,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

227,881,320

Owned by Insiders

2.04%

Owned by Institutions

―

Faron Pharmaceuticals Oy’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-371.76K

Employee Count

25

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Faron Pharmaceuticals Oy had revenue of ― and earned -9.29M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

1.15M

Operating Income

-8.86M

Pretax Income

―

Net Income

-9.29M

EBITDA

-9.03M

Earnings Per Share (EPS)

―

Beta

0.14

52-Week Price Change

-84.24%

50-Day Moving Average

35.94

200-Day Moving Average

48.66

Relative Strength Index (RSI)

17.80

Average Volume (3m)

47.99K

Faron Pharmaceuticals Oy upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

Mar 19, 2027

Ex-Dividend Date

―

Faron Pharmaceuticals Oy has ― in cash and marketable securities with GBX 2.36M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

GBX 2.36M

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Faron Pharmaceuticals Oy is GBX 1,000.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

GBX 1,000.00

Price Target Upside

3125.81% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

―

EPS Growth Forecast

53.99%